Bio-Rad Laboratories supplies instruments, reagents, and software for life science research and clinical diagnostics. Its products are widely used in protein and cell analysis, quality control, blood typing and transfusion medicine, and related laboratory workflows. The company serves academic labs, biopharma R&D, and clinical laboratories with a mix of recurring consumables and durable systems.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 585.4 | — | 64 | — |
| Q2 2025 | 651.6 | — | 317.8 | — |
| Q3 2025 | 653 | — | -341.9 | — |
| Q4 2025 | 693.2 | — | 720 | — |
| Q1 2026 | 592.1 | 1.1% | -527.1 | -923.6% |
| Q2 2026 | 651 | -0.1% | 371.4 | 16.9% |
All markets — KeepWinning global stock screener
Other companies on NYSE: New Oriental Education & Technology Group Inc. (EDU), SM Energy Company (SM), TFI International Inc. (TFII), Eldorado Gold Corporation (EGO), Kinetik Holdings Inc. (KNTK), Federal Realty Investment Trust (FRT)